The article argues that PRS are bad at identifying those who will develop disease but others say this is the same for widely used risk factors.
NorthShore University HealthSystem is among the first of many interested in implementing genetic testing and tracking the population health impact, according to Color.
After a successful pilot that recruited 1,000 patients, NorthShore will now engage 10,000 people to receive Color's genomic testing in their primary care.
The company also said it will release its first polygenic risk score for cardiovascular disease early this year.
Fortune reports that a Philadelphia-area hospital system is offering its employees free genetic testing.
Two recent publications suggest that DeepVariant's machine learning is far superior to traditional methods of variant calling, especially with hardware accelerators.
Othman Laraki, the CEO and co-founder of Color Genomics chats with Barron's Penta.
The company presented Color Data as a resource for variant classification scientists and hopes it will inspire industry peers to similarly share data.
Stat News reports that pharmacogenomics testing in psychiatry may be ahead of the science.
Researchers led by MD Anderson’s Karen Lu want to know the most efficient genetic counseling strategy as more people are getting screened for cancer risk genes.
In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.
The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.
People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.
MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.